Use of the nuclear matrix protein 22 Bladder Chek test (TM) in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer

Balci, Melih; Tuncel, Altug; Guzel, Ozer; Aslan, Yilmaz; Sezgin, Tezcan; Bilgin, Ovunc; Senel, Cagdas; Atan, ALİ

doi:10.1007/s11255-015-0921-4

Use of the nuclear matrix protein 22 Bladder Chek test (TM) in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer

Atıf İçin Kopyala

Balci M., Tuncel A., Guzel O., Aslan Y., Sezgin T., Bilgin O., ...Daha Fazla

INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.47, sa.3, ss.473-477, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 47 Sayı: 3
Basım Tarihi: 2015
Doi Numarası: 10.1007/s11255-015-0921-4
Dergi Adı: INTERNATIONAL UROLOGY AND NEPHROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.473-477
Anahtar Kelimeler: Bladder cancer, Diagnosis, NMP-22, Cytology, Second TUR
Gazi Üniversitesi Adresli: Evet

Özet

To investigate the diagnostic value of the nuclear matrix protein 22 (NMP-22) in residual tumors after complete transurethral resection (TUR) of bladder cancer.